Elevance Health raises share repurchase program by $5B

On January 24, the Audit Committee, pursuant to authorization granted by the Board of Directors, authorized a $5B increase to the common stock repurchase program. The company intends to utilize this authorization over a multi-year period, subject to market and industry conditions.